Cited by 132

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Herbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging steps

Teschke, Rolf, Eickhoff, Axel·2015·Frontiers in Pharmacology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fphar.2015.00072

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 25

  1. BfArM., 2002, Bundesinstitut für Arzneimittel und Medizinprodukte, Bonn. Federal Institute for Drugs and Medicinal Products in Germany. Rejection of Drug Risks, Step II. As related to: Kava-Kava (Piper methysticum)-Containing, and Kavain-Containing Drugs, Including Homeopathic Preparations with a Final Concentration up to, and Including D4. June 14, 2002
  2. BfArM., 2005, Bundesinstitut für Arzneimittel und Medizinprodukte (German regulatory agency). Bekanntmachung. Abwehr von Gefahren durch Arzneimittel, Stufe II, Anhörung: Schöllkraut-haltige Arzneimittel zur innerlichen Anwendung. May 6, 2005
  3. Court., 2014, Administrative Coiurt, Cologne, Germany. Court ruling 7 K 2197/12 of May 2010, 2014
  4. EMA., 2007, Assessment of Case Reports Connected to Herbal Medicinal Products Containing Cimicifugae Racemosae Rhizoma (Black Cohosh, Root). Issued May 8, 2007
  5. EMA., 2010, European Medicines Agency. Assessment Report on Chelidonium majus L., herba. Draft. November 25, 2010
  6. EMA., 2014, Herbal Medicinal Products
  7. IARC Monographs., 2002, Vol. 82. Introduction 1. History of Use Of Traditional Herbal Medicines
  8. MHRA., 2014, Herbal Medicines Regulation: Registered Traditional Herbal Medicines
  9. Nahin, 2009, Costs of Complementary and Alternative Medicine (CAM) and Frequency of Visits to CAM Practitioners: United States, 2007. National Health Statistics Reports; no. 18
  10. Nebraska., 2006, Nebraska Judgement of 8. September 2006
  11. NIH., 2013, National Institutes of Health, National Center for Complementary and Alternative medicine (NCCAM). Traditional Chinese medicine: An introduction. Last Updated October 2013
  12. NIH., 2014a, National Institutes of Health, National Center for Complementary and Alternative medicine (NCCAM). LiverTox. Drug record. Overview: Herbals and dietary supplements. introduction. Last Updated 04 November 2014
  13. NIH., 2014b, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). LiverTox. Agents included in LiverTox by drug class. Last Updated 4 November 2014
  14. NIH., 2014c, National Institutes of Health (NIH) and LiverTox: Drug Record. Ba Jiao Lian (Dysosma pleianthum). Last Updated19 May 2014
  15. Talari, 2010, Acute Hepatitis Associated with the Chinese Herbal Product Bai Shi Wan
  16. UN., 2000, United Nations Conference on Trade and Development. Systems and National Experiences for Protecting Traditional Knowledge, Innovations and Practices. Background Note by the UNCTAD Secretariat. Geneva. United Nations Conference on Trade and Development, 2000 (Document Reference TD/B/COM.1/EM.13/2). p.18
  17. WHO., 2000a, General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine
  18. WHO., 2000b, World Health Organization, The use of the WHO-UMC system for standardised case causality assessment. WHO Collaboratoring Centre for International Drug Monitoring (Uppsala Monitoring Centre, UMC), Database 2000
  19. WHO., 2002, World Health Organization. WHO Traditional Medicines Strategy 2002-2005
  20. WHO., 2003, Guideline on good agricultural and collection practices (GACP) for medicinal plants
  21. WHO., 2005, Regulatory Situation of Herbal Medicines. A Worldwide Review
  22. WHO., 2006, Technical Report Series, No. 937, 2006
  23. WHO., 2007a, World Health Organization. Assessments of the Risk of Hepatotoxicity with Kava Products
  24. WHO., 2007b, Guidelines for Assessing Quality of Herbal Medicines with Reference to Contaminants and Residues
  25. WHO., 2013, World Health Organization. WHO Traditional Medicines Strategy 2014-2023

Cited by

Sorted by citations

Metadata

Authors
Teschke, R., & Eickhoff, A.
Venue
Frontiers in Pharmacology
Published
2015-04-23
Volume
6
ISSN
1663-9812
Cited by
132
References
8

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review